ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 65 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,626,000 | -46.7% | 331,243 | -42.7% | 0.00% | -42.9% |
| Q2 2021 | $3,053,000 | +48.8% | 578,159 | +35.3% | 0.01% | +40.0% |
| Q1 2021 | $2,052,000 | +171.4% | 427,458 | +144.9% | 0.01% | +150.0% |
| Q4 2020 | $756,000 | +31.9% | 174,534 | +25.5% | 0.00% | 0.0% |
| Q3 2020 | $573,000 | +92.3% | 139,059 | +138.8% | 0.00% | +100.0% |
| Q3 2019 | $298,000 | +73.3% | 58,231 | +110.1% | 0.00% | 0.0% |
| Q2 2019 | $172,000 | -42.1% | 27,720 | -33.5% | 0.00% | 0.0% |
| Q1 2019 | $297,000 | -55.5% | 41,711 | -46.7% | 0.00% | -66.7% |
| Q4 2018 | $668,000 | +18.7% | 78,189 | +293.4% | 0.00% | 0.0% |
| Q4 2015 | $563,000 | -27.9% | 19,876 | -33.3% | 0.00% | -25.0% |
| Q2 2015 | $781,000 | – | 29,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |